Daisies offer a double boost for prostate cancer treatment

March 8, 2018, Freshscience
Katherine Morel and supervisor Professor Pam Sykes are using a compound from daisies to improve prostate cancer treatments. Credit: Flinders University

A compound derived from feverfew daisies can boost radiotherapy for the treatment of prostate cancer. The compound reduces the therapy's side effects and increases its cancer-killing ability.

Although to treat prostate can be highly effective, damage to nearby healthy tissues is common. This damage results in debilitating side effects, such as impotence and incontinence.

Research by Katherine Morel from the Flinders Centre for Innovation in Cancer at Flinders University has shown that parthenolide, an anti-inflammatory compound originally identified in feverfew daisies, can stimulate healthy tissues to protect themselves from damage during radiotherapy.

"In mice treated with the compound before radiation therapy, radiation-induced in their healthy tissues dropped by more than 70 percent," she says.

As an added bonus, the compound simultaneously doubled the ability of the radiotherapy to kill the prostate tumours in mice, by making the cancer cells more susceptible to the treatment.

"These results are exciting and lay the groundwork for future clinical trials," says Katherine.

"We hope that this compound could both improve survival rates for prostate cancer, as well as protect patients from the unwanted side effects of the treatment."

Feverfew daisies have long been used as a herbal treatment for migraines and other conditions due to the presence of like parthenolide in the plant. However this treatment uses a highly concentrated form of the compound, the equivalent Katherine says to eating a truckload of the daisies.

While the research is focussed on for now, Katherine says a similar approach could work when using radiotherapy to treat other types of cancer.

Explore further: Viral gene therapy could improve results from breast reconstruction after cancer treatment

Related Stories

Viral gene therapy could improve results from breast reconstruction after cancer treatment

January 24, 2018
A new type of gene therapy delivered using a virus could protect healthy tissues from the harmful side-effects of radiotherapy after cancer treatment, a new study reports.

PSMA PET/CT visualizes prostate cancer recurrence early, impacts radiation therapy

February 1, 2018
A nuclear medicine scan may locate prostate cancer recurrence after radical prostatectomy early after disease recurrence and could help guide salvage radiotherapy, according to new research from the University of California ...

Big data analysis predicts risk of radiotherapy side effects

November 7, 2017
Analysing big data to predict men's risk of side effects could help personalise radiotherapy treatment for prostate cancer, according to new research presented at the National Cancer Research Institute's (NCRI) Cancer Conference ...

Pelvis-targeting radiotherapy safe for prostate cancer patients

September 27, 2017
A form of radiotherapy targeting the pelvis is safe for men with advanced localised prostate cancer, according to a new study.

Discovery suggests better way to treat certain prostate cancers, lymphomas

November 10, 2017
Certain prostate cancers and lymphomas have a major genetic weakness that doctors can exploit to help save patients' lives, researchers at the University of Virginia School of Medicine have discovered.

Blood pressure tablets offer radiotherapy protection for prostate cancer patients

October 22, 2015
Blood pressure medication could help protect men from complications arising from radiotherapy for prostate cancer, a new study by researchers at the University of Dundee has found.

Recommended for you

Treatment shown to improve the odds against bone marrow cancer

December 15, 2018
Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Lethal combination: Drug cocktail turns off the juice to cancer cells

December 12, 2018
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth—this was discovered by researchers from the University of Basel's Biozentrum two years ago. In a follow-up study, ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.